ETF Holdings Breakdown of TERN

News associated with TERN

Barclays PLC Purchases 575,069 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Barclays PLC grew its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 444.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 704,371 shares of the company’s stock after purchasing an additional 575,069 shares during the quarter. Barclays PLC owned approximately 0.83% […] - 2025-04-28 07:59:03

Renaissance Technologies LLC Grows Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Renaissance Technologies LLC increased its position in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 30.0% in the 4th quarter, Holdings Channel reports. The firm owned 623,134 shares of the company’s stock after purchasing an additional 143,634 shares during the period. Renaissance Technologies LLC’s holdings in Terns Pharmaceuticals were worth $3,452,000 at the […] - 2025-04-23 07:37:03

Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Outperform Rating from JMP Securities

Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report)‘s stock had its “market outperform” rating reissued by research analysts at JMP Securities in a report issued on Monday,Benzinga reports. They currently have a $20.00 price objective on the stock. Separately, William Blair reissued a “market perform” rating on shares of Terns Pharmaceuticals in a research report on […] - 2025-04-23 05:10:57

Russell Investments Group Ltd. Trims Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Russell Investments Group Ltd. lessened its position in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 15.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 628,395 shares of the company’s stock after selling 116,292 shares during the quarter. Russell Investments Group Ltd.’s […] - 2025-04-17 09:35:15

ExodusPoint Capital Management LP Lowers Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

ExodusPoint Capital Management LP lowered its position in shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 99.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,816 shares of the company’s stock after selling 1,637,315 shares during […] - 2025-04-15 07:39:12

Norges Bank Purchases New Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Norges Bank bought a new position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 849,389 shares of the company’s stock, valued at approximately $4,706,000. Several other hedge funds and other institutional investors also recently added to or reduced […] - 2025-04-10 08:02:57

Tern (LON:TERN) Share Price Passes Below 200 Day Moving Average – What’s Next?

Tern Plc (LON:TERN – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1.40 ($0.02) and traded as low as GBX 1.15 ($0.01). Tern shares last traded at GBX 1.19 ($0.02), with a volume of 1,116,397 shares trading hands. Tern […] - 2025-03-28 07:58:57

Y Intercept Hong Kong Ltd Increases Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Y Intercept Hong Kong Ltd increased its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 84.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 67,002 shares of the company’s stock after acquiring an additional 30,610 shares during the period. […] - 2025-03-04 08:58:50

Tern (LON:TERN) Stock Price Passes Below 200-Day Moving Average – Should You Sell?

Shares of Tern Plc (LON:TERN – Get Free Report) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1.47 ($0.02) and traded as low as GBX 1.10 ($0.01). Tern shares last traded at GBX 1.17 ($0.01), with a volume of […] - 2025-03-04 08:24:48

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $18.30 Consensus Price Target from Brokerages

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has received an average rating of “Moderate Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month price objective among […] - 2025-03-03 06:18:50

Bleakley Financial Group LLC Increases Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN)

Bleakley Financial Group LLC increased its position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Free Report) by 262.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 48,296 shares of the company’s stock after acquiring an additional 34,984 shares during the period. Bleakley […] - 2025-02-12 08:58:51

TERN institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-05-08	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	38,591	USD 115,773
2025-05-08	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	38,591	USD 115,773 -0.8%
Total =		77,182	USD 231,546

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer